Skip to main content

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

Doc Pharma financial profile: approximately $24 million asset base, approximately $6.7 million in average annual revenue and approximately $3.2 million in average annual gross profit. Immediately accretive: expected to support margin expansion, profitability, and cash flow. Deepens vertical integration: expected to drive synergies, optimized production, economies of scale, expanded capacity, and a strengthened R&D engine. State-of-the-art production plant: GMP-licensed, approximately 59,000 square feet, built to the highest European standards, providing a clear growth avenue. Manufacturing excellence: a broad range of dosage forms, certified to GMP, ISO, Kosher, and Halal standards, with site registrations for the UAE, Qatar, Iraq and Lebanon. Boosts product portfolio: adds advanced and branded generics and OTC pharmaceutical products...

Continue reading

OVH Groupe enters into exclusive negotiations to acquire Gladia, expert in voice AI

Roubaix – June 11th, 2026 – OVH Groupe, a sovereign, global player and European leader in Cloud and AI, announces that it is entering into exclusive negotiations to acquire Gladia, the expert in AI speech-to-text (STT). This transaction aims to strengthen OVH Groupe’s expertise in multimodal and agentic generative AI.                  GladiaFounded in 2022 in Paris, Gladia is a French AI startup specializing in transcription and audio intelligence. Through a single API, the platform transcribes conversations in real time and in batch across more than 100 languages, turning audio data into structured, actionable information. Gladia today supports more than 300,000 developers and 2,000 enterprise customers, including HeyGen, Livestorm, Attention, Circleback, Method Financial, Recall.ai, and Leexi. Through this acquisition, OVH Groupe...

Continue reading

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing

– Acquisition of Azora and concurrent private placement positions the combined company to advance its pipeline through key clinical milestones in ulcerative colitis, including Phase 1 initiation in mid-2027 – Azora’s oral candidate, AT177, is a novel, colon‑targeted AhR agonist rationally engineered to have minimal systemic exposure and designed to mitigate safety concerns with systemically absorbed AhR agonists – $32 million in upfront financing with the potential to receive an additional $32 million under additional milestone tranches – Adial to host a conference call today, June 11, 2026 at 1pm ET GLEN ALLEN, Va. and LOS ANGELES, June 11, 2026 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that it has acquired Azora Therapeutics, Inc. (“Azora”),...

Continue reading

Top Aces to Acquire Select Global International, Strengthening Canada’s Sovereign Fighter Pilot Training Capability

Advancing Canadian‑Led Live‑Virtual‑Constructive Training for the RCAFTop Aces to Acquire SGITop Aces today announced an agreement to acquire Select Global International (“SGI”)MONTREAL, June 11, 2026 (GLOBE NEWSWIRE) — Top Aces Inc. (“Top Aces”), a global leader in advanced operational air combat training, today announced an agreement to acquire Select Global International (“SGI”), a Canadian defence company with deep expertise in simulator-based fighter pilot instruction supporting the Royal Canadian Air Force (“RCAF”). Founded in 2013, SGI has built a strong reputation delivering high-fidelity synthetic training solutions for CF-18 aircrew. The company is comprised of highly experienced former CF-18 instructor pilots, many of whom have recent operational and command experience within the RCAF. The acquisition brings...

Continue reading

AIFU Signs MOU to Acquire Industrial AI Company, Launching Strategic Transformation

SHENZHEN, China, June 11, 2026 (GLOBE NEWSWIRE) — AIFU Inc. (Nasdaq: AIFU) (the “Company” or “AIFU”),a leading AI-driven independent financial services platform in China, today announced that it has signed a non-binding Memorandum of Understanding (“MOU”) regarding a proposed acquisition of Peakleap Ventures Limited, a company specializing in industrial AI solutions for the solid waste recycling and resource recovery sector. The proposed acquisition is expected to support the Company’s strategic transformation into the industrial AI sector. Upon completion of the transaction, the Company expects to develop a dual-engine business ecosystem powered by “Industrial AI + Digital Finance,” achieving a strategic leap from a single-finance digital platform. According to information provided by Peakleap Ventures Limited,...

Continue reading

Advanced Integration Technology (AIT) Completes Acquisition of Futuramic Tool & Engineering

PLANO, Texas and WARREN, Mich., June 11, 2026 (GLOBE NEWSWIRE) — Advanced Integration Technology (AIT), the world’s largest provider of automation to the global aerospace and defense industry, announced that it completed the acquisition of Futuramic Tool & Engineering on June 1, 2026. The scope of the transaction includes Futuramic’s affiliates Sharp Tooling Solutions and Jordan Tool. John Couch will continue to lead Futuramic’s operations along with the existing management team. Transaction terms and financial details were not disclosed. Futuramic was founded in 1955 and has over 70 years of experience as a full-service engineering, fabrication, and installation provider. Futuramic has over 600,000 ft2 of facility space with a world-class collection of large-scale fabrication and large 5-axis machining capabilities. Futuramic...

Continue reading

Ebang International Announces Acquisition of Inner Mongolia Industrial Land for Amorphous and Nanocrystalline New Materials Project

IRVING, Texas, June 11, 2026 (GLOBE NEWSWIRE) — Ebang International Holdings Inc. (Nasdaq: EBON, the “Company,” “we,” “us” or “our”) today announced that its subsidiary had successfully won a bid for certain industrial land in Xinghe County, Ulaanqab City, Inner Mongolia Autonomous Region, China. The Company plans to construct production facilities for high-efficiency amorphous and nanocrystalline new materials on the site. This project will advance the Company’s expansion across renewable energy, new materials, and the green power industry chain, accelerating its strategic upgrade towards becoming a global provider of energy-related new material solutions. Leveraging Inner Mongolia’s abundant wind and photovoltaic resources and favorable clean energy policies, the Company will focus on the research, development, and manufacturing...

Continue reading

ZenaTech Signs Offer to Acquire a Western Canadian Geospatial and Land Surveying Company to Accelerate Drone as a Service in Utilities, Forestry, Agriculture and Government Sectors

VANCOUVER, British Columbia, June 11, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, today announces that it has signed an offer to acquire an established land surveying company with a regional footprint across Western Canada. The proposed acquisition builds on ZenaTech’s ongoing North American acquisition strategy and focuses on expanding its Drone as a Service presence in the Western Canadian geospatial sector, which includes critical industries such as infrastructure, utilities, forestry, mining, and agriculture. By combining established surveying and geomatics expertise with advanced drone operations and emerging...

Continue reading

GOWell Technology Limited and Inflection Point Acquisition Corp. V Announce Public Filing of Amendment No. 1 to the Registration Statement on Form F-4 in Connection with Proposed Business Combination

SINGAPORE and NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) — GOWell Technology Limited (“GOWell” or the “Company”), a global one-stop-shop for innovative well logging solutions in the energy sector, and Inflection Point Acquisition Corp. V (NASDAQ: IPEX) (“Inflection Point”), a special purpose acquisition company, have announced the public filing of an amendment (“Amendment No. 1”) to their joint registration statement on Form F-4 (the “Registration Statement”), initially filed with the U.S. Securities and Exchange Commission (the “SEC”). Amendment No. 1 and the initial Registration Statement are related to the previously announced business combination between Inflection Point and GOWell (the “Business Combination”). The Registration Statement contains a preliminary proxy statement/prospectus of Inflection Point that discloses important...

Continue reading

Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology

Ignite Proteomics is a pioneer in delivering pathway-level protein analytics designed to guide precision oncology.HONG KONG, June 11, 2026 (GLOBE NEWSWIRE) — Copley Acquisition Corp (NYSE: COPL) (“Copley”), a special purpose acquisition company and Ignite Proteomics, LLC (“Ignite” or “Ignite Proteomics”), a leader in pathway-level protein analytics to guide precision oncology, announced today that they have entered into a definitive business combination agreement (“BCA”). Upon the closing of the Combination, Copley and Ignite Proteomics will become wholly owned subsidiaries of a newly formed public holding company, which we intend to name Ignite Proteomics Holdings, Inc. (“PubCo”), and which will be listed on the New York Stock Exchange. “We are thrilled to partner with the team at Ignite Proteomics,” said Chibo Tang, Co-Chief...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.